Precigen CCO awarded 42,110 RSUs, converts to shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PRECIGEN, INC. Chief Commercial Officer Phil Tennant received a grant of 42,110 restricted stock units on March 18, 2026. Each RSU represents one share of common stock and vested immediately on the grant date. The RSUs were then exercised and converted into 42,110 shares of common stock at no cash exercise price, increasing his directly owned common stock holdings to 107,141 shares after these transactions. These actions reflect compensation-related equity awards and derivative exercises, not open-market buying or selling.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Stock Units | 42,110 | $0.00 | $0.00 |
| Exercise | Restricted Stock Units | 42,110 | $0.00 | $0.00 |
| Exercise | Common Stock | 42,110 | $0.00 | $0.00 |
Footnotes (2)
- F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
- F2. The RSUs vested immediately upon the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity compensation did PGEN executive Phil Tennant receive?
Were Phil Tennant’s recent PGEN transactions open-market purchases or sales?
What does the immediate vesting of PGEN restricted stock units mean for Phil Tennant?
Did Phil Tennant exercise any derivative securities of Precigen (PGEN)?
AI-generated analysis. How Rhea-AI works. Not financial advice.